Quarterly ResultMay 13, 2026, 07:32 AM
BrainsWay Q1 Revenue +35% to $15.5M; Net Income +100%
AI Summary
BrainsWay Ltd. reported strong first quarter 2026 financial results, with revenue growing 35% to $15.5 million and net income increasing over 100% to $2.3 million. Adjusted EBITDA more than doubled to $2.8 million. The company also shipped a record 117 Deep TMS Systems and saw remaining performance obligations rise 25% to $75 million. BrainsWay reiterated its full-year 2026 financial guidance, projecting revenue of $66 million to $68 million, and made strategic investments in Neurolief and BrainStim Health Inc.
Key Highlights
- Q1 2026 revenue increased 35% year-over-year to $15.5 million.
- Q1 2026 net income increased over 100% year-over-year to $2.3 million.
- Q1 2026 Adjusted EBITDA more than doubled to $2.8 million, up 117% year-over-year.
- Remaining performance obligations grew 25% year-over-year to approximately $75 million.
- Shipped a record 117 Deep TMS Systems, a 44% increase compared to prior year.
- Reiterated full-year 2026 revenue guidance of $66 million to $68 million.
- Cash and cash equivalents totaled $58.9 million as of March 31, 2026.
- Completed a $6 million convertible loan to Neurolief and a $1 million investment in BrainStim Health Inc.